Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Frontal Variant of Alzheimer's Disease: A Report of a Novel PSEN1 Mutation.

Monacelli F, Martella L, Parodi MN, Odetti P, Fanelli F, Tabaton M.

J Alzheimers Dis. 2019 Jun 6. doi: 10.3233/JAD-190363. [Epub ahead of print]

PMID:
31177233
2.

A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1.

Testa G, Staurenghi E, Giannelli S, Gargiulo S, Guglielmotto M, Tabaton M, Tamagno E, Gamba P, Leonarduzzi G.

Redox Biol. 2018 Jul;17:423-431. doi: 10.1016/j.redox.2018.05.009. Epub 2018 May 22.

3.

Preface.

Perry G, Avila J, Moreira PI, Sorensen AA, Tabaton M.

J Alzheimers Dis. 2018;64(s1):S1. doi: 10.3233/JAD-179945. No abstract available.

PMID:
29782320
4.

Birth of JAD: 20 Years Later.

Perry G, Avila J, Tabaton M, Zhu X.

J Alzheimers Dis. 2018;62(3):901. doi: 10.3233/JAD-180120. No abstract available.

5.

The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease.

Tamagno E, Guglielmotto M, Monteleone D, Manassero G, Vasciaveo V, Tabaton M.

J Alzheimers Dis. 2018;62(3):1241-1245. doi: 10.3233/JAD-170581. Review.

6.

The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer's and Vascular Disease.

Guglielmotto M, Monteleone D, Vasciaveo V, Repetto IE, Manassero G, Tabaton M, Tamagno E.

Front Aging Neurosci. 2017 Sep 29;9:320. doi: 10.3389/fnagi.2017.00320. eCollection 2017.

7.

Dual Mechanism of Toxicity for Extracellular Injection of Tau Oligomers versus Monomers in Human Tau Mice.

Manassero G, Guglielmotto M, Monteleone D, Vasciaveo V, Butenko O, Tamagno E, Arancio O, Tabaton M.

J Alzheimers Dis. 2017;59(2):743-751. doi: 10.3233/JAD-170298.

PMID:
28671129
8.

Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein.

Manassero G, Guglielmotto M, Zamfir R, Borghi R, Colombo L, Salmona M, Perry G, Odetti P, Arancio O, Tamagno E, Tabaton M.

Aging Cell. 2016 Oct;15(5):914-23. doi: 10.1111/acel.12500. Epub 2016 Jul 12.

9.

Relationship between balance and cognitive performance in older people.

Leandri M, Campbell J, Molfetta L, Barbera C, Tabaton M.

J Alzheimers Dis. 2015;45(3):705-7. doi: 10.3233/JAD-142883.

PMID:
25624415
10.

Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.

Monacelli F, Borghi R, Cammarata S, Nencioni A, Piccini A, Tabaton M, Odetti P.

J Alzheimers Dis. 2015;45(1):89-95. doi: 10.3233/JAD-142511.

PMID:
25471189
11.

Aβ1-42 monomers or oligomers have different effects on autophagy and apoptosis.

Guglielmotto M, Monteleone D, Piras A, Valsecchi V, Tropiano M, Ariano S, Fornaro M, Vercelli A, Puyal J, Arancio O, Tabaton M, Tamagno E.

Autophagy. 2014 Oct 1;10(10):1827-43. doi: 10.4161/auto.30001. Epub 2014 Aug 12.

12.

Monomeric Aβ1-42 and RAGE: key players in neuronal differentiation.

Piras S, Furfaro AL, Piccini A, Passalacqua M, Borghi R, Carminati E, Parodi A, Colombo L, Salmona M, Pronzato MA, Marinari UM, Tabaton M, Nitti M.

Neurobiol Aging. 2014 Jun;35(6):1301-8. doi: 10.1016/j.neurobiolaging.2014.01.002. Epub 2014 Jan 10.

PMID:
24484607
13.

Survival rate in patients affected by dementia followed by memory clinics (UVA) in Italy.

Ientile L, De Pasquale R, Monacelli F, Odetti P, Traverso N, Cammarata S, Tabaton M, Dijk B.

J Alzheimers Dis. 2013;36(2):303-9. doi: 10.3233/JAD-130002.

PMID:
23609761
14.

Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study.

Fornaro M, McCarthy MJ, De Berardis D, De Pasquale C, Tabaton M, Martino M, Colicchio S, Cattaneo CI, D'Angelo E, Fornaro P.

Neuropsychiatr Dis Treat. 2013;9:243-51. doi: 10.2147/NDT.S41557. Epub 2013 Feb 15.

15.

Transcriptional and post-transcriptional regulation of β-secretase.

Tamagno E, Guglielmotto M, Monteleone D, Vercelli A, Tabaton M.

IUBMB Life. 2012 Dec;64(12):943-50. doi: 10.1002/iub.1099. Review.

16.

Aβ1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation.

Guglielmotto M, Monteleone D, Boido M, Piras A, Giliberto L, Borghi R, Vercelli A, Fornaro M, Tabaton M, Tamagno E.

Aging Cell. 2012 Oct;11(5):834-44. doi: 10.1111/j.1474-9726.2012.00854.x. Epub 2012 Aug 1.

17.

β-amyloid 1-42 induces physiological transcriptional regulation of BACE1.

Piccini A, Borghi R, Guglielmotto M, Tamagno E, Cirmena G, Garuti A, Pollero V, Cammarata S, Fornaro M, Messa M, Colombo L, Salmona M, Perry G, Tabaton M.

J Neurochem. 2012 Sep;122(5):1023-31. doi: 10.1111/j.1471-4159.2012.07834.x. Epub 2012 Jul 11.

18.

Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairment.

Di Maria E, Giorgio E, Uliana V, Bonvicini C, Faravelli F, Cammarata S, Novello MC, Galimberti D, Scarpini E, Zanetti O, Gennarelli M, Tabaton M.

J Alzheimers Dis. 2012;29(3):699-705. doi: 10.3233/JAD-2012-112006.

19.

The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.

Nunomura A, Tamaoki T, Motohashi N, Nakamura M, McKeel DW Jr, Tabaton M, Lee HG, Smith MA, Perry G, Zhu X.

J Neuropathol Exp Neurol. 2012 Mar;71(3):233-41. doi: 10.1097/NEN.0b013e318248e614.

20.

Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer disease.

Musicco M, Padovani A, Sorbi S, Scarpini E, Caffarra P, Cappa S, Clerici F, Tabaton M, Caltagirone C, Bonavita V, Bruni AC, Bruno G, Federico A, Ferrarese C, Marra C, Nacmias B, Parnetti L, Pettenati C, Sorrentino G, Tagliavini F, Mariani C.

Neurol Sci. 2012 Feb;33(1):201-8. doi: 10.1007/s10072-011-0825-8. Epub 2011 Nov 5.

PMID:
22057264
21.

Amyloid-β production: major link between oxidative stress and BACE1.

Tamagno E, Guglielmotto M, Monteleone D, Tabaton M.

Neurotox Res. 2012 Oct;22(3):208-19. doi: 10.1007/s12640-011-9283-6. Epub 2011 Oct 15. Review.

22.

A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules.

Castellani RJ, Gupta Y, Sheng B, Siedlak SL, Harris PL, Coller JM, Perry G, Lee HG, Tabaton M, Smith MA, Wang X, Zhu X.

Lab Invest. 2011 Dec;91(12):1777-86. doi: 10.1038/labinvest.2011.149. Epub 2011 Oct 3.

23.

Amyloid-β₄₂ activates the expression of BACE1 through the JNK pathway.

Guglielmotto M, Monteleone D, Giliberto L, Fornaro M, Borghi R, Tamagno E, Tabaton M.

J Alzheimers Dis. 2011;27(4):871-83. doi: 10.3233/JAD-2011-110884.

PMID:
21897006
24.

The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies.

Stone JG, Siedlak SL, Tabaton M, Hirano A, Castellani RJ, Santocanale C, Perry G, Smith MA, Zhu X, Lee HG.

J Neuropathol Exp Neurol. 2011 Jul;70(7):578-87. doi: 10.1097/NEN.0b013e3182204414.

25.

RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration.

Massone S, Vassallo I, Castelnuovo M, Fiorino G, Gatta E, Robello M, Borghi R, Tabaton M, Russo C, Dieci G, Cancedda R, Pagano A.

J Cell Biol. 2011 May 30;193(5):851-66. doi: 10.1083/jcb.201011053.

26.

17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease.

Massone S, Vassallo I, Fiorino G, Castelnuovo M, Barbieri F, Borghi R, Tabaton M, Robello M, Gatta E, Russo C, Florio T, Dieci G, Cancedda R, Pagano A.

Neurobiol Dis. 2011 Feb;41(2):308-17. doi: 10.1016/j.nbd.2010.09.019. Epub 2010 Oct 1.

PMID:
20888417
27.

Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease.

Borghi R, Piccini A, Barini E, Cirmena G, Guglielmotto M, Tamagno E, Fornaro M, Perry G, Smith MA, Garuti A, Tabaton M.

J Alzheimers Dis. 2010;22(3):771-5. doi: 10.3233/JAD-2010-100729.

PMID:
20847436
28.

AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation.

Guglielmotto M, Aragno M, Tamagno E, Vercellinatto I, Visentin S, Medana C, Catalano MG, Smith MA, Perry G, Danni O, Boccuzzi G, Tabaton M.

Neurobiol Aging. 2012 Jan;33(1):196.e13-27. doi: 10.1016/j.neurobiolaging.2010.05.026. Epub 2010 Jul 17.

29.

Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment.

Storace D, Cammarata S, Borghi R, Sanguineti R, Giliberto L, Piccini A, Pollero V, Novello C, Caltagirone C, Smith MA, Bossù P, Perry G, Odetti P, Tabaton M.

Arch Neurol. 2010 Jul;67(7):867-72. doi: 10.1001/archneurol.2010.137.

PMID:
20625095
30.

Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease.

Moh CF, Siedlak SL, Tabaton M, Perry G, Castellani RJ, Smith MA.

J Neurosci Methods. 2010 Jul 15;190(2):244-7. doi: 10.1016/j.jneumeth.2010.05.010. Epub 2010 May 16. Review.

31.

Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors.

Guglielmotto M, Giliberto L, Tamagno E, Tabaton M.

Front Aging Neurosci. 2010 Feb 9;2:3. doi: 10.3389/neuro.24.003.2010. eCollection 2010.

32.

Oxidative stress in Alzheimer disease: a possibility for prevention.

Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA.

Neuropharmacology. 2010 Sep-Oct;59(4-5):290-4. doi: 10.1016/j.neuropharm.2010.04.005. Epub 2010 Apr 13. Review.

PMID:
20394761
33.

Artificial neural networks identify the predictive values of risk factors on the conversion of amnestic mild cognitive impairment.

Tabaton M, Odetti P, Cammarata S, Borghi R, Monacelli F, Caltagirone C, Bossù P, Buscema M, Grossi E.

J Alzheimers Dis. 2010;19(3):1035-40. doi: 10.3233/JAD-2010-1300.

PMID:
20157257
34.

The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment.

Di Maria E, Cammarata S, Parodi MI, Borghi R, Benussi L, Galli M, Galimberti D, Ghidoni R, Gonella D, Novello C, Pollero V, Perroni L, Odetti P, Scarpini E, Binetti G, Tabaton M.

J Alzheimers Dis. 2010;19(3):909-14. doi: 10.3233/JAD-2010-1285.

PMID:
20157246
35.

Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment.

Smith MA, Zhu X, Tabaton M, Liu G, McKeel DW Jr, Cohen ML, Wang X, Siedlak SL, Dwyer BE, Hayashi T, Nakamura M, Nunomura A, Perry G.

J Alzheimers Dis. 2010;19(1):363-72. doi: 10.3233/JAD-2010-1239. Review.

36.

Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease.

Tabaton M, Perry G, Zhu X, Lee HG, Casadesus G, Smith MA.

Am J Pathol. 2010 Feb;176(2):540-1. doi: 10.2353/ajpath.2010.090856. Epub 2009 Dec 17. No abstract available.

37.

Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells.

Su B, Wang X, Lee HG, Tabaton M, Perry G, Smith MA, Zhu X.

Neurosci Lett. 2010 Jan 14;468(3):267-71. doi: 10.1016/j.neulet.2009.11.010. Epub 2009 Nov 13.

PMID:
19914335
38.

Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study.

Gustaw-Rothenberg KA, Siedlak SL, Bonda DJ, Lerner A, Tabaton M, Perry G, Smith MA.

Exp Gerontol. 2010 Jan;45(1):47-52. doi: 10.1016/j.exger.2009.10.003. Epub 2009 Oct 9.

39.

Signaling effect of amyloid-beta(42) on the processing of AbetaPP.

Tabaton M, Zhu X, Perry G, Smith MA, Giliberto L.

Exp Neurol. 2010 Jan;221(1):18-25. doi: 10.1016/j.expneurol.2009.09.002. Epub 2009 Sep 9. Review.

40.

Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment.

Cammarata S, Borghi R, Giliberto L, Pardini M, Pollero V, Novello C, Fornaro M, Vitali A, Bracco L, Caltagirone C, Bossù P, Odetti P, Tabaton M.

J Alzheimers Dis. 2009;18(2):267-71. doi: 10.3233/JAD-2009-1144.

PMID:
19584444
41.

N-terminal truncated pyroglutamyl beta amyloid peptide Abetapy3-42 shows a faster aggregation kinetics than the full-length Abeta1-42.

D'Arrigo C, Tabaton M, Perico A.

Biopolymers. 2009 Oct;91(10):861-73. doi: 10.1002/bip.21271.

PMID:
19562755
42.

Coffee "breaks" Alzheimer's disease.

Tabaton M.

J Alzheimers Dis. 2009;17(3):699-700; discussion 701-2. doi: 10.3233/JAD-2009-1089. No abstract available.

PMID:
19542633
43.

Mutant presenilin 1 increases the expression and activity of BACE1.

Giliberto L, Borghi R, Piccini A, Mangerini R, Sorbi S, Cirmena G, Garuti A, Ghetti B, Tagliavini F, Mughal MR, Mattson MP, Zhu X, Wang X, Guglielmotto M, Tamagno E, Tabaton M.

J Biol Chem. 2009 Apr 3;284(14):9027-38. doi: 10.1074/jbc.M805685200. Epub 2009 Feb 5.

44.

The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha.

Guglielmotto M, Aragno M, Autelli R, Giliberto L, Novo E, Colombatto S, Danni O, Parola M, Smith MA, Perry G, Tamagno E, Tabaton M.

J Neurochem. 2009 Feb;108(4):1045-56. doi: 10.1111/j.1471-4159.2008.05858.x.

45.

Balance features in Alzheimer's disease and amnestic mild cognitive impairment.

Leandri M, Cammisuli S, Cammarata S, Baratto L, Campbell J, Simonini M, Tabaton M.

J Alzheimers Dis. 2009;16(1):113-20. doi: 10.3233/JAD-2009-0928.

PMID:
19158427
46.

Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional role.

Giliberto L, Zhou D, Weldon R, Tamagno E, De Luca P, Tabaton M, D'Adamio L.

Mol Neurodegener. 2008 Sep 2;3:12. doi: 10.1186/1750-1326-3-12.

47.

JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1.

Tamagno E, Guglielmotto M, Giliberto L, Vitali A, Borghi R, Autelli R, Danni O, Tabaton M.

Neurobiol Aging. 2009 Oct;30(10):1563-73. doi: 10.1016/j.neurobiolaging.2007.12.015. Epub 2008 Feb 6.

PMID:
18255190
48.

Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein.

Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, Muraca G, Danni O, Zhu X, Smith MA, Perry G, Jo DG, Mattson MP, Tabaton M.

J Neurochem. 2008 Feb;104(3):683-95. Epub 2007 Nov 14.

49.

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.

Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T.

Nat Med. 2007 Nov;13(11):1359-62. Epub 2007 Oct 14.

PMID:
17934472
50.

Increased autophagic degradation of mitochondria in Alzheimer disease.

Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G.

Autophagy. 2007 Nov-Dec;3(6):614-5. Epub 2007 Aug 14.

PMID:
17786024

Supplemental Content

Loading ...
Support Center